Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Toshio Odani & John A. Chiorini. (2019) Targeting primary Sjögren’s syndrome. Modern Rheumatology 29:1, pages 70-86.
Read now
Read now
Articles from other publishers (24)
Jing Zhou, Shoko Onodera & Qing Yu. (2022)
Inhibition of
NLRP3
inflammasome activity by
MCC950
leads to exacerbation of Sjӧgren's syndrome pathologies in non‐obese diabetic mice
. Immunology 168:4, pages 697-708.
Crossref
Crossref
Ruei-Nian Li, Tsan-Teng Ou, Chia-Hui Lin, Yuan-Zhao Lin, Tzu-Jung Fang, Yi-Jing Chen, Chia-Chun Tseng, Wan-Yu Sung, Cheng-Chin Wu & Jeng-Hsien Yen. (2023) NLRP3 Gene Polymorphisms in Rheumatoid Arthritis and Primary Sjogren’s Syndrome Patients. Diagnostics 13:2, pages 206.
Crossref
Crossref
Xiaoyu Xu, Linshuang Wang, Qian Chen, Zikang Wang, Xun Pan, Xike Peng, Miao Wang, Dongfeng Wei, Yanping Li & Bin Wu. (2022) Decoding the Mechanism of CheReCunJin Formula in Treating Sjögren’s Syndrome Based on Network Pharmacology and Molecular Docking. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-14.
Crossref
Crossref
Julie Sarrand, Laurie Baglione, Dorian Parisis & Muhammad Soyfoo. (2022) The Involvement of Alarmins in the Pathogenesis of Sjögren’s Syndrome. International Journal of Molecular Sciences 23:10, pages 5671.
Crossref
Crossref
Jiajia Cui, Hui Li, Tianling Wang, Qin Shen, Yuanhao Yang, Xiujuan Yu & Huaixia Hu. (2022) Novel Immune-Related Genetic Expression for Primary Sjögren's Syndrome. Frontiers in Medicine 8.
Crossref
Crossref
Danielle J. Beetler, Katelyn A. Bruno & DeLisa Fairweather. 2022. Translational Autoimmunity. Translational Autoimmunity
167
188
.
Yuan Yao, Jin-Fen Ma, Christopher Chang, Ting Xu, Cai-Yue Gao, M. Eric Gershwin & Zhe-Xiong Lian. (2020) Immunobiology of T Cells in Sjögren’s Syndrome. Clinical Reviews in Allergy & Immunology 60:1, pages 111-131.
Crossref
Crossref
Amrita Srivastava & Helen P. Makarenkova. (2020) Innate Immunity and Biological Therapies for the Treatment of Sjögren’s Syndrome. International Journal of Molecular Sciences 21:23, pages 9172.
Crossref
Crossref
Marco Tutino, Giorgia Mattei, Niccolò Paoloni & Valentina Santolamazza. (2019) Corporate governance, CSR and financial performances: What types of relationships exist between these dimensions?. Corporate governance, CSR and financial performances: What types of relationships exist between these dimensions?.
Keiko Aota, Koichi Kani, Tomoko Yamanoi, Koh-ichi Nakashiro, Naozumi Ishimaru & Masayuki Azuma. (2018) Distinct Regulation of CXCL10 Production by Cytokines in Human Salivary Gland Ductal and Acinar Cells. Inflammation 41:4, pages 1172-1181.
Crossref
Crossref
Özgün Özçaka, Esin Alpöz, Ayşe Nalbantsoy, Gonca Karabulut & Yasemin Kabasakal. (2018) Clinical periodontal status and inflammatory cytokines in primary Sjögren syndrome and rheumatoid arthritis. Journal of Periodontology 89:8, pages 959-965.
Crossref
Crossref
Soledad Retamozo, Alejandra Flores-Chavez, Marta Consuegra-Fernández, Francisco Lozano, Manuel Ramos-Casals & Pilar Brito-Zerón. (2018) Cytokines as therapeutic targets in primary Sjögren syndrome. Pharmacology & Therapeutics 184, pages 81-97.
Crossref
Crossref
Young-Su Yi. (2018) Role of inflammasomes in inflammatory autoimmune rheumatic diseases. The Korean Journal of Physiology & Pharmacology 22:1, pages 1.
Crossref
Crossref
Aigli G. Vakrakou, Alexandros Polyzos, Efstathia K. Kapsogeorgou, Dimitris Thanos & Menelaos N. Manoussakis. (2018) Impaired anti-inflammatory activity of PPARγ in the salivary epithelia of Sjögren's syndrome patients imposed by intrinsic NF-κB activation. Journal of Autoimmunity 86, pages 62-74.
Crossref
Crossref
Jeremy Kiripolsky, Liam G McCabe, Daniel P Gaile & Jill M Kramer. (2017) Myd88 is required for disease development in a primary Sjögren's syndrome mouse model. Journal of Leukocyte Biology 102:6, pages 1411-1420.
Crossref
Crossref
Jeremy Kiripolsky, Liam G. McCabe & Jill M. Kramer. (2017) Innate immunity in Sjögren's syndrome. Clinical Immunology 182, pages 4-13.
Crossref
Crossref
Sabrina Fechtner, David A. Fox & Salahuddin Ahmed. (2016) Transforming growth factor β activated kinase 1: a potential therapeutic target for rheumatic diseases. Rheumatology, pages kew301.
Crossref
Crossref
Sigrid M. C. Broekaert, Almut Böer-Auer, Katrin Kerl, Ilka Herrgott, Xenia Schulz, Gisela Bonsmann, Randolf Brehler & Dieter Metze. (2016) Neutrophilic Epitheliotropism Is a Histopathological Clue to Neutrophilic Urticarial Dermatosis. The American Journal of Dermatopathology 38:1, pages 39-49.
Crossref
Crossref
Jessica E. Brandt, Roberta Priori, Guido Valesini & DeLisa Fairweather. (2015) Sex differences in Sjögren’s syndrome: a comprehensive review of immune mechanisms. Biology of Sex Differences 6:1.
Crossref
Crossref
P. R. Sada, D. Isenberg & C. Ciurtin. (2014) Biologic treatment in Sjogren's syndrome. Rheumatology 54:2, pages 219-230.
Crossref
Crossref
José C Crispín. (2015) Lessons from Sjögren’s syndrome etiopathogenesis: Novel cellular and molecular targets. World Journal of Immunology 5:3, pages 152.
Crossref
Crossref
Giuseppe Lopalco, Luca Cantarini, Antonio Vitale, Florenzo Iannone, Maria Grazia Anelli, Laura Andreozzi, Giovanni Lapadula, Mauro Galeazzi & Donato Rigante. (2015) Interleukin-1 as a Common Denominator from Autoinflammatory to Autoimmune Disorders: Premises, Perils, and Perspectives. Mediators of Inflammation 2015, pages 1-21.
Crossref
Crossref
DeLisa Fairweather. 2015. Skin, Mucosa and Menopause. Skin, Mucosa and Menopause
359
381
.
Jill M. Kramer. (2014) Early events in Sjögren’s Syndrome pathogenesis: The importance of innate immunity in disease initiation. Cytokine 67:2, pages 92-101.
Crossref
Crossref